CMV infection can lead to significant immune system modulation. The virus can remain latent in the body, reactivating when the immune system is compromised, such as in patients undergoing chemotherapy or organ transplantation. This reactivation can complicate treatment regimens and lead to opportunistic infections. CMV can also induce an inflammatory response that may affect the body's ability to process toxins and drugs, which is a key consideration in toxicology.
